Daily Graphs Free Week
Investor’s Business Daily sister company, Daily Graphs, is running a free week to their premium tools over at investors.com. My favorite and most used tool is the Daily Graphs Custom Screen Wizard.
All Daily Screens on this blog come from one of the eight scans I developed and described in detail in the post: Fundamental Screens and Scans
So far, the two scans below have been giving us the most opportunities in the market.
1. Quality Stocks with a new IPO within the past two Years
This screen scans for high quality stocks that have debuted to the market with the past two years (IPO’s).
- Earnings Per Share (EPS) Rating: Greater than or equal to: 30
- Relative Price Strength (RS) Rating: Greater than or equal to: 30
- Market Capitalization (MM): Greater than or equal to: 100.0
- Current Price: Greater than or equal to: 10.000
- Current 50-Day Average Volume (1000): Greater than or equal to: 100
- IPO Date: After 2006
2. Institutional Sponsorship Increasing
This next screen looks for high quality stocks that have increasing institutional fund sponsorship from one quarter to the next. As you know, this is very important for any stocks I cover and then buy. Every case study on this blog includes detailed institutional sponsorship analysis.
- Earnings Per Share (EPS) Rating: From 60 to 99
- Relative Price Strength (RS) Rating: From 60 to 99
- % of the number of Mutual Funds Owning for Current Quarter vs. Prior Quarter: Greater than or equal to: 10%
- Stocks trading at new 52-Week High and Percentage price is below 52-Week High: From 0 to 15
- Current 50-Day Average Volume (1000): Greater than or equal to: 100
Enjoy the free week; the tools are excellent for all CANSLIM, swing, trend trading and buy-at-new-high investors.
Like this article? Subscribe to my free RSS feed!
Hi Chris,
Using your IPO screen, what do you think about ANW?
Sandro,
The stock (ANW) was second on the screen as you already know. It has been moving with power over the past couple days but is extended from an ideal buy point. The ideal buy was the push above $23 per share or $24 on the point and figure chart.
Glad to see someone trying out my screens!
Chris,
So how do you pare down the long list of stocks that appear on the screen? You can’t possibly look at the technicals for each and every stock. Do you analyze the ones that have a positive price chg & positive Vol % chg vs 50 Day Avg (or some other criteria to help pare down the list)?
Sorry for all the questions but I’m trying to really understand how you identify potential winning stocks. If you’ve already addressed this in previous posts, please refer me to them.
As always, Thx for your help.
Rgds,
Sandro
Sandro,
I do. I only look at stocks making a positive change in price and then I study the ones with above average volume. Sometimes, none of the stocks have above average volume so I just use the ones with positive price changes. Since I dod this every single night, I usually catch most if not all stocks makign a move (I don’t trade them all but I at least see them in some capacity).
I look at hundreds of charts each night. It takes about one hour to review the charts (I am very good at it after years of doing it every night), I look at four charts for each stock (all on one screen): daily, weekly, intraday and point and figure.
When you mean above avg volume are you using a positive “Vol % chg vs 50 Day Avg” displayed on the custom daily graphs?
Also, in evaluating the four charts, what are you looking for in each chart? Would it be possible for you to take the “Quality Stocks with a new IPO within the past two Years” screen and provide the pared down list based on your chart evaluation?
Sandro,
That is exactly what my daily screen do when I present them a few times each week. It is my cut down list based on technicals.
Chris,
Have you seen or used the AAII screeners with their Stock Investor Pro? I’d be interested in your and others thoughts on these screeners compared with those at Daily Graphs Online?
John
John,
I have looked at the AAII screens but have never used them in my research. Sorry I can’t answer your question any further.